Patents by Inventor Claudia Gravekamp

Claudia Gravekamp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF CANCER USING RECALL ANTIGENS DELIVERED BY ATTENUATED BACTERIA
    Publication number: 20220125901
    Abstract: Methods, pharmaceutical compositions and vaccines comprising an attenuated bacteria that expresses a recall antigen are disclosed for treatment of cancer.
    Type: Application
    Filed: November 16, 2021
    Publication date: April 28, 2022
    Applicant: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
    Inventor: Claudia Gravekamp
  • Treatment of cancer using recall antigens delivered by attenuated bacteria
    Patent number: 11213577
    Abstract: Methods, pharmaceutical compositions and vaccines comprising an attenuated bacteria that expresses a recall antigen are disclosed for treatment of cancer.
    Type: Grant
    Filed: April 26, 2016
    Date of Patent: January 4, 2022
    Assignee: Albert Einstein College of Medicine, Inc.
    Inventor: Claudia Gravekamp
  • Radiobacteria for therapy of cancer
    Patent number: 10702614
    Abstract: A method of treating a tumor in a subject, or reducing or preventing metastasis of a tumor in a subject, is provided comprising administering to the subject an amount of a bacteria labelled with, or comprising, one or more radionuclides so as to treat the tumor in the subject, or so as to reduce or prevent metastasis of the tumor in the subject. Radiobacteria-containing compositions and pharmaceutical compositions are also provided.
    Type: Grant
    Filed: February 3, 2012
    Date of Patent: July 7, 2020
    Assignee: ALBERT EINSTEIN COLLEGE OF MEDICINE
    Inventors: Ekaterina Dadachova, Claudia Gravekamp, Arturo Casadevall
  • Method for producing radiobacteria for therapy of cancer
    Patent number: 10398792
    Abstract: A method of producing radiobacteria is provided, especially radiolisteria-32P. Compositions and methods of use thereof are also provided.
    Type: Grant
    Filed: October 19, 2015
    Date of Patent: September 3, 2019
    Assignee: Albert Einstein College of Medicine
    Inventors: Claudia Gravekamp, Ekaterina Dadachova, Dinesh Chandra
  • TREATMENT OF CANCER USING RECALL ANTIGENS DELIVERED BY ATTENUATED BACTERIA
    Publication number: 20180104320
    Abstract: Methods, pharmaceutical compositions and vaccines comprising an attenuated bacteria that expresses a recall antigen are disclosed for treatment of cancer.
    Type: Application
    Filed: April 26, 2016
    Publication date: April 19, 2018
    Applicant: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
    Inventor: Claudia Gravekamp
  • METHOD FOR PRODUCING RADIOBACTERIA FOR THERAPY OF CANCER
    Publication number: 20170333578
    Abstract: A method of producing radiobacteria is provided, especially radiolisteria-32P. Compositions and methods of use thereof are also provided.
    Type: Application
    Filed: October 19, 2015
    Publication date: November 23, 2017
    Applicant: Albert Einstein College of Medicine, Inc.
    Inventors: Claudia Gravekamp, Ekaterina Dadachova, Dinesh Chandra
  • RADIOBACTERIA FOR THERAPY OF CANCER
    Publication number: 20140147379
    Abstract: A method of treating a tumor in a subject, or reducing or preventing metastasis of a tumor in a subject, is provided comprising administering to the subject an amount of a bacteria labelled with, or comprising, one or more radionuclides so as to treat the tumor in the subject, or so as to reduce or prevent metastasis of the tumor in the subject. Radiobacteria-containing compositions and pharmaceutical compositions are also provided.
    Type: Application
    Filed: February 3, 2012
    Publication date: May 29, 2014
    Applicant: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Ekaterina Dadachova, Claudia Gravekamp, Arturo Casadevall
  • Compositions and methods comprising a MAGE-b antigen
    Publication number: 20070264279
    Abstract: The present invention provides MAGE-b peptides, recombinant polypeptides comprising same, recombinant nucleotide molecules encoding same, recombinant Listeria strains comprising same, and immunogenic and therapeutic methods utilizing same.
    Type: Application
    Filed: March 28, 2007
    Publication date: November 15, 2007
    Inventors: Claudia Gravekamp, Yvonne Paterson, Paulo Maciag